Vimarsana
Biggest News Aggregation in the World

Bdr Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bdr Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bdr Pharma Today - Breaking & Trending Today

BDR Pharma launches patient-friendly prostrate cancer therapy - Vimarsana News

BDR Pharma launches patient-friendly prostrate cancer therapy

India Business News: BDR Pharma launches BDENZA (Enzalutamide), the world's first oral solution for prostate cancer management. BDENZA is priced at Rs 27,000 for 150mL, of

Mumbai real estate update: BDR Pharma promoter purchases 2 apartments worth Rs 80 crore in Worli - Vimarsana News

Mumbai real estate update: BDR Pharma promoter purchases 2 apartments worth Rs 80 crore in Worli

The deal is for two apartments in Raheja Artesia, where Ipsita Dasgupta, the former Apple executive, had purchased flat for Rs 22.52 crore.

Mumbai: BDR Pharma CMD's family buys luxury apartments in Mumbai's Worli for Rs 81 cr - Vimarsana News

Mumbai: BDR Pharma CMD's family buys luxury apartments in Mumbai's Worli for Rs 81 cr

The performance in terms of stamp duty collection led by the heightened activity in premium and mid-income housing segments have also pushed the state exchequers revenue higher for several months. In the first 10 months of the current year, the state government has already fetched over Rs 9,220 crore through stamp duty collection surpassing the all-time high of over Rs 8,893 crore recorded in 2022.

BDR Pharma CMD's family buys apartments in Mumbai's Worli for Rs 81 crore, ET RealEstate - Vimarsana News

BDR Pharma CMD's family buys apartments in Mumbai's Worli for Rs 81 crore, ET RealEstate

Mumbai: The performance in terms of stamp duty collection led by the heightened activity in premium and mid-income housing segments have also pushed the state exchequer’s revenue higher for several months.

BDR Pharma launches generic APALUTAMIDE to treat Prostate cancer in India - Vimarsana News

BDR Pharma launches generic APALUTAMIDE to treat Prostate cancer in India

Apalutamide plus ADT (androgen-deprivation therapy) arm shows a significant decrease in the risk of disease progression and reduces risk of mortality by 35% amongst Non-Metastatic Castration resistant...